FIELD: medicine, pharmacy. SUBSTANCE: invention relates to drugs used for treatment of diseases complicated with inflammatory processes, presence of pus and necrotic tissues and accompanying with tissue structure changes. Drug has a complex of collagenolytic proteinases from hydrocole digestive organs including serine collagenolytic proteinases, metalloproteinases and proteinases with terminal alanine residues and acceptable carrier. EFFECT: increased activity of agent. 4 cl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF TREATMENT OF PATIENT WITH DISEASES ACCOMPANYING PUS FORMATION AND/OR NECROTIC TISSUES | 1997 |
|
RU2149644C1 |
RATE REGULATING AGENT OF PREPARATION EFFECT FOR INJECTION AND PREPARATION FOR INJECTION (VARIANTS) | 1997 |
|
RU2141324C1 |
ACTIVE COMPONENT OF COSMETIC AGENT AND COSMETIC AGENT (VARIANTS) | 1997 |
|
RU2141310C1 |
METHOD OF CELL CULTURE PREPARING | 1997 |
|
RU2126832C1 |
WOUND-HEALING AGENT SHOWING THE BROAD SPECTRUM ACTION | 1995 |
|
RU2093166C1 |
AGENT "KOLLAGEL" FOR TREATMENT OF SUPPURATIVE-NECROTIC WOUNDS AND BURNS | 1997 |
|
RU2139044C1 |
COMPOSITION FOR TREATMENT OF SUPPURATIVE-TROPHIC ULCER AND DECUBITUS | 1992 |
|
RU2074709C1 |
ENZYME PREPARATION FROM HEPATOPANCREAS OF COMMERCIAL CRAB SPECIES AND METHOD FOR PRODUCTION OF THE SAME | 2004 |
|
RU2280076C1 |
COMPOSITION OF INDIVIDUAL PROTEOLYTIC FERMENTS | 2006 |
|
RU2365623C2 |
METHOD FOR PRODUCTION OF COLLAGENASE INHIBITOR FROM HEPATOPANCREAS OF COMMERCIAL CRAB SPECIES | 2005 |
|
RU2292393C2 |
Authors
Dates
2001-01-10—Published
1997-11-28—Filed